# A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

> **NCT06780410** · PHASE3 · RECRUITING · sponsor: **Gan & Lee Pharmaceuticals.** · enrollment: 240 (estimated)

## Conditions studied

- Primary Hyperlipidemia

## Interventions

- **DRUG:** Bempedoic Acid Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06780410
- **Lead sponsor:** Gan & Lee Pharmaceuticals.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06780410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06780410, "A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06780410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*